arrow
T

Tine W. Hansen

Steno Diabetes Center Copenhagen
H指数:58
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials

糖尿病中降低白蛋白尿治疗对心血管预测性鞘脂的影响:ROTATE试验的事后分析

2026-07-310
OAAI
Genetic determinants of childhood blood pressure and heart rate in relation to adult health outcomes: the consortium of childhood blood pressure

儿童血压和心率与成人健康结局相关的遗传决定因素:儿童血压研究联盟

2026-04-270
OA
End Point-Based Threshold for the Ambulatory Arterial Stiffness Index

基于终点的肱动脉僵硬指数阈值

2026-03-011
PRE
Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?

研究者发起的丹麦实用随机STENO INTEN-CT试验研究方案:对2型糖尿病患者进行亚临床冠状动脉疾病的筛查和干预是否能够减少心血管事件?

2025-12-150
OA
Association between carotid-femoral pulse wave velocity and cardiovascular disease in individuals with moderate blood pressure: a systematic review and individual participant meta-analysis

颈股动脉脉搏波速度与中度血压个体中心血管疾病之间的关联:一项系统综述和个体参与者meta分析

2025-12-120
OA
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease

左心室射血分数储备及其与心肌灌注、冠状动脉钙化及应变在2型糖尿病合并无显性心血管疾病中的关联

2025-09-160
OAAI
Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis

动态血压监测、欧洲指南目标值和心血管结局:一项个体患者数据Meta分析

2025-04-181
OA
Possible Glycemic Effects of Vagus Nerve Stimulation Evaluated by Continuous Glucose Monitoring in People with Diabetes and Autonomic Neuropathy: A Randomized, Sham-Controlled Trial
2025-01-010
PRE
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study

螺内酯洗脱对2型糖尿病和肾脏疾病高风险患者长期治疗后蛋白尿的影响-优先研究的观察性随访

2024-10-280
PRE
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
HEART
IF4.4
2024-05-092
OAAI